Bone Marrow Mesenchymal Stem Cell and Mononuclear Cell Combination Therapy in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study with 8-Year Follow-Up

By
Jamie Kang
-
0
25
Investigators explored the long-term effects of combining bone marrow MSCs with mononuclear cells in the treatment of type 2 diabetes mellitus.
[Stem Cell Research & Therapy]
Full Article